RGDX - Response Genetics, Inc. Announces Fourth Quarter and Year-End 2013 Financial Results --- Q4 DX Revenue Increases 25% to $3.2 Million Relative to Q3 2013 and Gross Margin Increases to 48% ---
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.